Geoffrey E. Harris - Jan 17, 2023 Form 4 Insider Report for Vyant Bio, Inc. (VYNT)

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Stock symbol
VYNT
Transactions as of
Jan 17, 2023
Transactions value $
$0
Form type
4
Date filed
1/19/2023, 03:30 PM
Previous filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award +5.71K +40.66% 19.8K Jan 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 17, 2023, the Reporting Person was granted 5,712 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date.